Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Biomarker Research|September 10, 2024
Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinomaZhao-Ru Dong, Meng-Ya Zhang, Ling-Xin Qu, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decadesCheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan, et al.
Journal of Gastroenterology and Hepatology|January 4, 2021
Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysisZi-Niu Ding, Zhao-Ru Dong, Zhi-Qiang Chen, et al.
Journal of Cancer|January 3, 2022
Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapiesYu-Chuan Yan, Guang-Xiao Meng, Zi-Niu Ding, et al.
Frontiers in Oncology|March 8, 2021
Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-AnalysisKai-Xuan Liu, Jian-Guo Hong, Rui Wu, et al.
Cell Death Discovery|March 7, 2025
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolismChun-Cheng Yang, Yu-Chuan Yan, Guo-Qiang Pan, et al.
Expert Review of Gastroenterology & Hepatology|January 10, 2023
The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysisCheng-Long Han, Bao-Wen Tian, Chun-Cheng Yang, et al.
Journal of Cancer|June 7, 2021
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survivalZhao-Ru Dong, Zhi-Qiang Chen, Xiao-Yun Yang, et al.
Immunotherapy|December 20, 2022
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysisBao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, et al.
Immunotherapy|May 4, 2023
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysisHui Liu, Chun-Cheng Yang, Yun-Long Ma, et al.
Pageof 5